Kian‐Huat Lim

机构：Barnes-Jewish Hospital, Washington University in St. Louis, Jewish Hospital · ORCID：0000-0002-2766-200X

发表论文 294 篇 · 总被引 10362 次 · h-index 42

代表论文

• Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers (2024 · Science · 被引 121)
• Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy (2024 · Science Translational Medicine · 被引 42)
• Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer (2024 · Nature Communications · 被引 34)
• Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer (2025 · Clinical Cancer Research · 被引 16)
• Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205). (2024 · Journal of Clinical Oncology · 被引 15)
• Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells (2024 · Nucleic Acid Therapeutics · 被引 14)